Ceruloplasmin

TIBC (Total Iron Binding Capacity)

DHA (Docosahexaenoic Acid)

Reverse T3 (rT3)

Insulin

Platelet Count

MCHC (Mean Corpuscular Hemoglobin Concentration)

Apolipoprotein A1

TNF-α (Tumor Necrosis Factor-alpha)

Serum Cortisol

AST (Aspartate Aminotransferase)

ALT (Alanine Aminotransferase)

Sodium

Alkaline Phosphatase (ALP)

GGT (Gamma-Glutamyl Transferase)

ANA (Antinuclear Antibody)

ApoA/ApoB Ratio

MCV (Mean Corpuscular Volume)

25(OH)D (25-Hydroxyvitamin D)

BUN/Creatinine Ratio

Total Testosterone

Creatinine

Basophils (Absolute)

Total Protein

Fibrinogen

HS-CRP (High-Sensitivity C-Reactive Protein)

Fasting Insulin

LDL Particle Number

Eosinophils (Absolute)

IL-6 (Interleukin-6)

Chloride

Neutrophils (Absolute)

EPA (Eicosapentaenoic Acid)

WBC (White Blood Cell Count)

NRBC (Nucleated Red Blood Cells)

Immature Granulocytes

Free T3 (Triiodothyronine)

TSH (Thyroid Stimulating Hormone)

VLDL Cholesterol (calculated)

Monocytes (Absolute)

Discover the significance of fibrinogen as a biomarker for longevity. Learn how monitoring this protein can provide valuable insights into aging and disease risk.

Fibrinogen

In the study of longevity, biomarkers play a crucial role in assessing an individual’s health and predicting their potential lifespan. One such biomarker is fibrinogen, a protein found in blood plasma that plays a key role in blood clotting. Elevated levels of fibrinogen have been associated with an increased risk of cardiovascular disease and mortality, making it an important biomarker to monitor for longevity purposes. By tracking fibrinogen levels over time, researchers and healthcare professionals can gain valuable insights into an individual’s cardiovascular health and overall risk of age-related diseases, offering potential opportunities for intervention and improved longevity.

Biomarker Explained

Biomarkers are essential tools in the study of longevity, providing valuable insight into an individual’s health and potential lifespan. One such biomarker is fibrinogen, a protein found in blood plasma with a significant role in blood clotting. Elevated levels of fibrinogen have been linked to an increased risk of cardiovascular disease and mortality, making it a crucial biomarker to monitor for longevity purposes. Interpreting fibrinogen levels involves tracking its concentration in the blood over time. Elevated levels may indicate a higher risk of cardiovascular disease and mortality, suggesting a potential need for intervention to improve overall longevity. By monitoring fibrinogen levels, researchers and healthcare professionals can gain important insights into an individual’s cardiovascular health and overall risk of age-related diseases. Understanding and interpreting fibrinogen levels allows for the identification of potential opportunities for intervention, such as lifestyle modifications or targeted medical treatments, to improve an individual’s longevity. By leveraging the insights provided by fibrinogen as a biomarker, healthcare professionals can work towards implementing proactive measures to optimize cardiovascular health and overall longevity.

Keywords:

biomarker, longevity, fibrinogen, blood plasma, cardiovascular disease, mortality, intervention, concentration, healthcare professionals, age-related diseases, lifestyle modifications, medical treatments, proactive measures, cardiovascular health.

Complete Patient Intake Form

Continue Browsing Our Offers